z-logo
open-access-imgOpen Access
Efficacy and safety of CalliSpheres® drug-eluting beads transarterial chemoembolization in patients with secondary liver cancer: a preliminary result from CTILC study
Author(s) -
Xia Wu,
Shihong Ying,
Jing Huang,
Changsheng Shi,
Jiansong Ji,
Zhiyi Peng,
GuanHui Zhou,
Zhichao Sun,
JunHui Sun,
Wenqiang Yu,
Wenhao Hu,
Xin Zhang,
Jian Zhou,
Guoliang Shao,
Zhihai Yu,
Qinming Hou,
Wenjiang Gu,
Tiefeng Li,
Xiaoxi Xie,
Guohong Cao,
Haijun Du,
Dedong Zhu,
Huanhai Xu,
Jun Han,
Wenbin Ji,
Jian Fang,
Ling Li,
Jiaping Zheng,
Jun Luo,
Yutang Chen,
Tingyang Hu,
Hongjie Hu,
Xiaohua Guo
Publication year - 2019
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr.2019.06.44
Subject(s) - medicine , nausea , vomiting , gastroenterology , adverse effect , liver cancer , liver function , response evaluation criteria in solid tumors , prospective cohort study , cancer , complete response , surgery , chemotherapy , phases of clinical research

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom